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Abstract
Oxidative stress leads to increased risk for osteoarthritis (OA)
but the precise mechanism remains unclear. We undertook this
study to clarify the impact of oxidative stress on the progression
of OA from the viewpoint of oxygen free radical induced
genomic instability, including telomere instability and resulting
replicative senescence and dysfunction in human chondrocytes.
Human chondrocytes and articular cartilage explants were
isolated from knee joints of patients undergoing arthroplastic
knee surgery for OA. Oxidative damage and antioxidative
capacity in OA cartilage were investigated in donor-matched
pairs of intact and degenerated regions of tissue isolated from
the same cartilage explants. The results were histologically
confirmed by immunohistochemistry for nitrotyrosine, which is
considered to be a maker of oxidative damage. Under treatment
with reactive oxygen species (ROS; 0.1 µmol/l H2O2) or an
antioxidative agent (ascorbic acid: 100.0 µmol/l), cellular
replicative potential, telomere instability and production of
glycosaminoglycan (GAG) were assessed in cultured
chondrocytes. In tissue cultures of articular cartilage explants,
the presence of oxidative damage, chondrocyte telomere length
and loss of GAG to the medium were analyzed in the presence
or absence of ROS or ascorbic acid. Lower antioxidative
capacity and stronger staining of nitrotyrosine were observed in
the degenerating regions of OA cartilages as compared with the
intact regions from same explants. Immunostaining for
nitrotyrosine correlated with the severity of histological changes
to OA cartilage, suggesting a correlation between oxidative
damage and articular cartilage degeneration. During continuous
culture of chondrocytes, telomere length, replicative capacity
and GAG production were decreased by treatment with ROS.
In contrast, treatment with an antioxidative agent resulted in a
tendency to elongate telomere length and replicative lifespan in
cultured chondrocytes. In tissue cultures of cartilage explants,
nitrotyrosine staining, chondrocyte telomere length and GAG
remaining in the cartilage tissue were lower in ROS-treated
cartilages than in control groups, whereas the antioxidative
agent treated group exhibited a tendency to maintain the
chondrocyte telomere length and proteoglycan remaining in the
cartilage explants, suggesting that oxidative stress induces
chondrocyte telomere instability and catabolic changes in
cartilage matrix structure and composition. Our findings clearly
show that the presence of oxidative stress induces telomere
genomic instability, replicative senescence and dysfunction of
chondrocytes in OA cartilage, suggesting that oxidative stress,
leading to chondrocyte senescence and cartilage ageing, might
be responsible for the development of OA. New efforts to
prevent the development and progression of OA may include
strategies and interventions aimed at reducing oxidative damage
in articular cartilage.
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Introduction
Articular cartilage matrix undergoes substantial structural,
molecular, and mechanical changes with ageing, including
surface fibrillation, alteration in proteoglycan structure and
composition, increased collagen cross-linking, and
decreased tensile strength and stiffness [1,2].
Asc2P = ascorbic acid-2-O-phosphate; DMEM = Dulbecco's modified Eagle's medium; GAG = glycosaminoglycan; NO = nitric oxide; OA = oste-
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Deterioration in chondrocyte function accompanies these
changes in the extracellular matrix [3]. Recently, attention
has been given to the suggestion that cartilage ageing and
chondrocyte senescence play an important role in the
pathogenesis and development of osteoarthritis (OA) [4,5].
Several reports revealed that chondrocyte senescence
contributes to the risk for cartilage degeneration by
decreasing the ability of chondrocytes to maintain and
repair the articular cartilage tissue [4-6]. The mitotic and
synthetic activity of chondrocytes decline with advancing
donor age [5]. In addition, human chondrocytes become
less responsive to anabolic mechanical stimuli with ageing
and exhibit an age-related decline in response to growth
factors such as the anabolic cytokine insulin-like growth
factor-I [6]. These findings provide evidence supporting the
concept that chondrocyte senescence may be involved in
the progression of cartilage degeneration.
Telomeres, the terminal guanine-rich sequences of chro-
mosomes, are structures that function in the stabilization of
the chromosome during replication by protecting the chro-
mosome end against exonucleases [7,8]. The telomere
DNA may function as a timing mechanism that, when
reduced to a critical length, signals a cell to stop dividing
and to enter cellular senescence [7-9]. More recent reports
demonstrated that the telomere length of chondrocytes
shortened with donor ageing and that decreased mean tel-
omere length was closely related to the increase in senes-
cence-associated  β-galactosidase expression in human
chondrocytes, suggesting that chondrocyte senescence,
at least in part, participates in the age-related loss of
chondrocyte function responsible for deterioration in artic-
ular cartilage structure and function [10]. An understanding
of the mechanisms of chondrocyte senescence would be
helpful to our efforts to devise new approaches to the pre-
vention and treatment of OA.
Mechanical and chemical stresses are thought to induce
increased free radical production, consequently leading to
oxidative damage to the tissue [11-14]. Oxidative damage
not only can initiate apoptosis through caspase activation
but also may lead to irreversible growth arrest, similar to
replicative senescence [11,12,15]. Furthermore, it has
been reported that oxygen free radicals (O2
- and peroxyni-
trite) directly injure the guanine repeats in the telomere
DNA, indicating that oxidative stress directly leads to tel-
omere erosion, regardless of cell active division [16]. Gen-
erally, it is now thought that oxidative stress/antioxidative
capacity may be prominent among factors that control tel-
omere length [17-19]. These findings strongly suggest that
oxidative stress could induce chondrocyte telomere insta-
bility with no requirement for cell division in articular carti-
lage, leading to chondrocyte senescence.
Numerous reports have demonstrated that oxidative dam-
age due to the over-production of nitric oxide (NO) and
other reactive oxygen species (ROS) may be involved in the
pathogenesis of OA [20-23]. However, because of the
highly reactive nature of these oxygen reactive species and
their short half-lives, it had been difficult to investigate oxi-
dative damage in vivo [24]. ROS and NO cannot be
directly and accurately measured in a cartilage sample.
Recently, a reaction product of ROS and NO, namely nitro-
tyrosine, was used as evidence of oxidative damage in sev-
eral ageing tissues [25,26]. Loeser and coworkers [26]
demonstrated that nitrotyrosine is over-expressed in normal
cartilage from elder donors and in OA cartilage, suggesting
the presence of oxidative damage in ageing and degenera-
tive cartilage. These findings provide evidence to support
the concept that oxidative stress in articular cartilage
affects chondrocyte function, resulting in changes in carti-
lage homeostasis that are relevant to cartilage ageing,
chondrocyte senescence and the development of OA.
Based on the properties of chondrocyte senescence and
oxidative stress in OA cartilage, as discussed above, we
postulated that oxidative stress induces telomere instability
and dysfunction in chondrocytes, subsequently resulting in
cartilage ageing and the development of OA through a
mechanism involving the acceleration of chondrocyte
senescence. It is now thought that oxidative stress/antioxi-
dative capacity is prominent among factors that control tel-
omere length, and hence replicative lifespan [17,18]. To
clarify the role of oxidative damage in the pathogenesis of
OA, we looked for the presence of oxidative damage in
degenerated cartilage from OA patients and examined
whether chemical oxidative stress (ROS) affects chondro-
cyte telomere DNA, replicative lifespan, and function in cul-
tured chondrocytes and in explants of articular cartilage.
We also examined the effects of the antioxidative agent
ascorbic acid on the oxidative stress induced downregula-
tion of cellular lifespan and function in chondrocytes.
Methods
Articular cartilage tissue and chondrocyte culture
Articular cartilage samples were obtained from OA patients
(n = 9) who had undergone arthoplastic knee surgery (all
female, age [mean ± standard deviation] 61.5 ± 5.4 years).
The patients had given informed consent, in accordance
with the ethical committee of the university. All samples
were obtained in accordance with institutional protocol,
with review board approval. Donor articular cartilage sam-
ples were evaluated macroscopically using a modified Col-
lins scale from 0 to 5, as described previously [27-29].
To obtain sufficient numbers of cells for the experiments,
cultured chondrocytes were isolated from macroscopically
intact zones of cartilage. Cartilage tissue was cut into small
pieces, washed in phosphate-buffered saline (PBS), andAvailable online http://arthritis-research.com/content/7/2/R380
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digested in Dulbecco's modified Eagle's medium (DMEM;
Sigma, St. Louis, MO, USA) containing 1.5 mg/ml colla-
genase B (Sigma). Digestion was carried out at 37°C over-
night on a shaking platform. Cells were centrifuged,
washed with PBS, and plated with fresh DMEM.
Basically, chondrocytes were cultured in DMEM supple-
mented with 10% heat-inactivated foetal calf serum, 2
mmol/l l-glutamine, 25 mmol/l HEPES, and 100 units/ml
penicillin and streptomycin at 37°C in a humidified 5% CO2
atmosphere [30]. To avoid loss of chondrocyte phenotypes
during passages, we used cultured chondrocytes only from
passages 1–4. In parallel cultures, we checked the cell
morphology and potential to produce proteoglycan in order
to examine whether chondrocyte phenotype had been
maintained during the passage. Data from chondrocyte
mass cultures with loss of chondrocyte phenotypes were
excluded from the analysis.
Chondrocytes were cultured in the presence of an antioxi-
dant (100 µmol/l ascorbic acid-2-O-phosphate [Asc2P;
Wako Junyaku, Tokyo, Japan]) or a ROS (H2O2) at a con-
centration of 0.1 µmol/l, which was not cytotoxic to the
cells [17]. We had already investigated the effect of H2O2
(0.1–500.0 µmol/l) on chondrocyte viability in vitro. Con-
centrations of 0.1–200.0 µmol/l of H2O2 exhibited no inhib-
itory effects on chondrocyte viability (data not shown). In
addition, we had also studied the time course of H2O2
treatment (0.1–100.0 µmol/l) in vitro. Based on our prelim-
inary experiments, in the present study we conducted the
cell culture and the organ culture in the presence or
absence of H2O2 (0.1 µmol/l).
In each culture group, the medium including freshly pre-
pared Asc2P or H2O2 was changed every 2 days. Human
chondrocytes were subcultured weekly. At each passage,
the total number of collected cells in the dish was deter-
mined. Then, 2.5–5.0 × 105 cells were transferred to a new
dish for the next passage, and the number of attached cells
was determined 6 hours after seeding. From each passage,
the remaining cells after subculture were stored at -180°C
until the analysis of cellular activity, telomere length and tel-
omerase activity was conducted.
Oxidative stress in human articular cartilage
We compared the degree of oxidative stress (antioxidative
potential) of the intact cartilage with that of degenerative
cartilage tissue. Cartilage samples from the same donor
joint were cut and divided into two groups (the degener-
ated region group, which exhibited macroscopic changes
of OA; and the intact region group, which was macroscop-
ically normal).
In these donor matched pairs of articular cartilage samples,
antioxidative potential of the tissue was measured using an
assay that is based on reduction of Cu2+ to Cu+ and the
measurement was conducted according to the manufac-
turer's instructions (OXIS Health Products, Inc., Portland,
OR, USA). This assay measures the total contribution of all
antioxidants in the tissue sample. The results of the assay
were calculated as mmol/l uric acid equivalents, and
expressed as a ratio of antioxidative potential of the degen-
erating region to that of the corresponding intact region
from each donor.
Immunohistochemistry
For immunostaining of human articular cartilage, paraffin
blocks of articular cartilage tissues were prepared using
standard histological procedures. Serial sections of paraf-
fin-embedded bone and cartilage tissues were cut and
immunostained using an antibody for nitrotyrosine. The
sections were deparaffinized and hydrated. Then, the slides
were stained using horseradish peroxidase method [26].
Briefly, the slides were blocked with 3% H2O2. After block-
ing nonspecific protein binding with blocking agent (Dako,
Carpinteria, CA, USA), the sections were incubated with a
monoclonal antibody to nitrotyrosine (1:100 dilution; BIO-
MOL Research Laboratories Inc., Plymouth Meeting, PA,
USA) for 1 hour at room temperature, followed by incuba-
tion with biotinylated goat anti-mouse IgG (Dako) for 30
min at room temperature. After washing with PBS, the sec-
tions were incubated with streptavidin–horseradish peroxi-
d a s e  c o m p l e x  ( L S A B 2  k i t ;  Dako) for 30 min at room
temperature We used diaminobenzidine (Sigma) as a visi-
ble peroxidase reaction product. Sections were counter-
stained with Mayer's haematoxylin (Sigma).
Cells positive and negative for nitrotyrosine were counted
in the 20 areas of cartilage at 200× magnification (0.785
mm2/field). The level of immunostaining for nitrotyrosine
was expressed as a mean number of nitrotyrosine-positive
cells per field.
Chondrocyte activity
Chondrocyte activity was measured as the production of
glycosaminoglycan (GAG) by cultured chondrocytes [15].
After undergoing continuous treatment with ROS or ascor-
bic acid (initial subculture at the start of the experiment: 1
× 105 cells/dish, chondrocytes from passage 2), the cells
were collected with trypsin and washed with PBS. Then,
chondrocytes (1 × 105 cells/dish) were plated in the cul-
ture dishes and incubated for 12 hours, and the amount of
GAG in the supernatant was measured using a spectro-
photometric assay with dimethylmethylene blue (Aldrich
Chemical, Milwaukee, WI, USA) [31].
Determination of the lifespan of cultured chondrocytes
The increase in cumulative population doublings at each
subculture was calculated based on the number of cells
attached and the cell yield at the time of the nextArthritis Research & Therapy    Vol 7 No 2    Yudoh et al.
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subculture. Population zero was the primary culture of
human chondrocytes, and the number of each successive
generation was calculated using the following formula
[32,33]: generation number at the start of the subculture +
log2([the number of collected cells at the time of the next
subculture]/[the number of attached cells at the start of the
subculture]). Senescence was defined as less than one
population doubling in 4 weeks. The in vitro lifespan
(remaining replicative capacity) was expressed as popula-
tion doublings up to cellular senescence [34].
Telomere length of cultured chondrocytes
Telomere length was determined using terminal restriction
fragment Southern blot analysis, as described previously
[35,36]. Genomic DNA from 106 chondrocytes from each
subculture (initial subculture at the start of the experiment:
1 × 106 cells/dish, chondrocytes from passage 3 or 4) was
digested with 400 µl DNA extraction buffer (100 mmol/l
NaCl, 40 mmol/l Tris [pH 8.0], 20 mmol/l EDTA, and 0.5%
SDS) and proteinase K (0.1 mg/ml). Extraction was per-
formed using phenol chloroform. Extracted DNA (5–10 µg)
was digested with 10 units of MspI and RsaI (Boehringer
Mannheim, Indianapolis, IN, USA) for 12–24 hours at 37°C.
The integrity of the DNA before digestion and the com-
pleteness of digestion were monitored by gel electrophore-
sis. Electrophoresis of digested genomic DNA was
performed in 0.5% agarose gels in 45 mmol/l Tris-borate
EDTA buffer (pH 8.0) for a total of 660–700 V-h. After elec-
trophoresis, gels were depurinated in 0.2 N HCl, denatured
in 0.5 mol/l NaOH and 1.5 mol/l NaCl, transferred to a
nylon membrane using 20× SSC, and dried for 1 hour at
70°C. The telomeric probe (TTAGGG)3 (Genset, La Jolla,
CA, USA) was 5' end-labelled with [α-32P]ATP using T4
PNK (Boehringer Mannheim). Prehybridization and hybridi-
zation were performed at 50°C using 5× Denhardt's, which
was composed of 5× SSC, 0.1 mol/l Na2HPO4, 0.01 mol/
l Na4P2O7, 30 µg/ml salmon sperm DNA, and 0.1 mmol/l
ATP. The mean terminal restriction fragment length was
determined from densitometric analysis of autoradiograms,
as described previously [35].
Tissue culture of human articular cartilage
Procedures for preparing articular cartilage were generally
the same as mentioned above. Briefly, articular cartilage
was excised in small, full-depth slices (typically 1.0 cm
square) from patients with OA (n = 4) who had undergone
arthroplastic knee surgery (all females; ages 61, 65, 67 and
68 years). The cartilage explants were cut, weighed and
divided into three groups as follows: control group, antioxi-
dative agent + oxidative stress treated group, and oxidative
stress treated group. Control and experimental cartilage
explants (site-matched pairs) were placed in individual
dishes (diameter 6.0 cm) with 10.0 ml DMEM with 10%
foetal bovine serum, 100 units/ml penicillin/streptomycin.
The process of harvesting the cartilage tissue resulted in
significant catabolic activity that was measurable in the
absence of interleukin-1 stimulation, presumably due to
secretion of proteases in response to trauma. The contribu-
tion of this basal catabolic activity could be minimized by
culturing for 24 hours before aspiration of the culture
medium, washing with PBS, and adding fresh culture
medium [37,38]. For the antioxidative agent + oxidative
stress treated group, the cartilage explants were incubated
in the culture medium with 100.0 µmol/l Asc2P plus 0.1
µmol/l H2O2. For the oxidative stress treated group, the
explants were incubated in the culture medium in the pres-
ence of 0.1 µmol/l H2O2. For each group, culture medium
including freshly prepared Asc2P or H2O2 was changed
every day.
At the end of each incubation period (48, 72, 96, 120 and
120 hours), the cartilage samples and the culture media
were collected and re-weighed for analyses. The cartilage
samples were washed with PBS. Some parts of cartilage
samples were fixed with 4% paraformaldehyde at 4°C, and
then paraffin blocks were prepared using standard histo-
logical procedures. For nitrotyrosine staining, the sections
were deparaffinized and hydrated, and then were immunos-
tained using antibody for nitrotyrosine in accordance with
the method described above.
Other cartilage samples and supernatants were stored at -
80°C for the determination of GAG concentration and iso-
lated chondrocyte telomere length. Catabolic changes to
GAG in cartilage were analyzed by determining the GAG
content remaining in cartilage tissue relative to the total
amount of GAG in the culture (GAG released into the cul-
ture media plus GAG in the tissue) in the presence of the
antioxidative agent or ROS [2,39]. GAG contents were
measured using a spectrophotometric assay mentioned
above. Procedures for cultured chondrocyte preparation
from tissue cultured explants and telomere length assay
were generally the same as those described above.
Statistical analysis
Results were expressed as a mean value ± standard devia-
tion. Comparison of the means was performed by analysis
of variance. P  < 0.05 was considered statistically
significant.
Results
Oxidative damage in human articular cartilage tissues
To determine whether oxidative damage was present in OA
degenerated cartilage, we measured the antioxidative
potential of the intact region and degenerated region iso-
lated from the same articular cartilage tissue of patients
who had undergone arthroplastic knee surgery. In the
donor-matched pair of intact and degenerated regions from
same articular cartilage, the antioxidative potential in the
intact region was significantly greater than that in theAvailable online http://arthritis-research.com/content/7/2/R380
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degenerated region of articular cartilage in the OA patient
group (n = 9; mean percentage antioxidative capacity of
degenerative cartilage compared with intact cartilage: 45.5
± 16.8%), suggesting that degenerated cartilage may
exhibit more oxidative damage than an intact region from
the same OA cartilage.
Presence of nitrotyrosine in articular cartilage from 
patients with osteoarthritis
To clarify the relationship between oxidative damage and
development of OA, immunostaining for nitrotyrosine was
examined in the donor-matched pair of intact and degener-
ated articular cartilage sections from the same OA sample.
Figure 1 shows a representative example of immunohisto-
chemical staining for nitrotyrosine in the articular cartilage
from an OA patient (female, 67 years old). Immunostaining
for nitrotyrosine was most apparent in the degenerated
regions of articular cartilage that showed histological
changes consistent with OA (nine patients; positive cells/
field, intact cartilage versus degenerated cartilage: 0.3 ±
0.1 versus 7.4 ± 2.4; P < 0.01). Nine of 10 donor samples
with degenerated regions were highly positive for nitrotyro-
sine. Nitrotyrosine was present both within chondrocytes
and in the cartilage matrix, and was seen mainly in the more
superficial regions. The degree of immunostaining for nitro-
tyrosine (number of positive cells/field) correlated with the
level of histological change in donor cartilage tissues (n =
9, r2 = 0.4671; P < 0.01). In contrast to the immunostaining
in the degenerated regions, almost all intact regions iso-
lated from the same articular cartilage were negative for
nitrotyrosine, even in superficial and deep zones (Fig. 1).
In vitro chondrocyte activity under the different oxidative 
conditions
Figure 2 shows that GAG synthesis from cultured chondro-
cytes decreased gradually in a time dependent manner,
regardless of the presence of H2O2 or an antioxidative
agent in vitro. The H2O2 treated group showed a significant
decrease in proteoglycan production by chondrocytes as
compared with the control group at any incubation time. In
contrast, in the antioxidative agent group the level of prote-
oglycan production tended to increase as compared with
Figure 1
Representative immunohistochemical staining for nitrotyrosine in donor articular cartilage Representative immunohistochemical staining for nitrotyrosine in donor articular cartilage. Cartilage sections were immunostained using an anti-
nitrotyrosine antibody. In donor-matched pairs of degenerative and intact regions from same cartilage explants (67-year-old donor), positive immu-
nostaining for nitrotyrosine was observed in chondrocytes and in the cartilage matrix in degenerated regions, whereas the intact region from same 
cartilage sample showed no positive staining for nitrotyrosine. Original magnification: 40×.Arthritis Research & Therapy    Vol 7 No 2    Yudoh et al.
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that in control groups, although no significant differences
were observed between control groups and antioxidative
agent groups at any incubation time (Fig. 2).
Chondrocyte replicative potential under the different 
oxidative conditions
To clarify the effect of oxidative stress on the replicative
potential of chondrocytes, we analyzed the cellular replica-
tive potential of chondrocytes in the presence of the antiox-
idative agent or ROS in vitro. As shown in Fig. 3, the
replicative potential of cultured chondrocytes was
expressed as the cumulative number of cells dividing at
each incubation time. After 20 days of incubation the H2O2
treated group exhibited lesser replicative potential as com-
pared with the control group at any incubation time. In con-
trast, treatment with the antioxidative agent increased the
cellular replicative potential at all incubation times after 20
days (Fig. 3).
During the 4 weeks after a 50- to 60-day incubation, the
cumulative population doubling levels of all groups reached
a plateau, indicating that the cultured chondrocytes in each
group reached the limit of their ability to divide, namely cel-
lular senescence, after about 8 weeks of incubation. The
Figure 2
Glycosaminoglycan (GAG) production from cultured chondrocytes under different oxidative conditions Glycosaminoglycan (GAG) production from cultured chondrocytes under different oxidative conditions. After the incubation times indicated, in the 
presence of 0.1 µmol/l H2O2 or 100.0 µmol/l ascorbic acid (initial subculture at the start of the experiment: 1 × 105 cells/dish, chondrocytes at pas-
sage 2), chondrocytes were collected and transferred to a new culture dish (1 × 105 cells/dish). Following 12 hours of incubation, the amount of 
GAG in the supernatant was measured using a spectrophotometric assay with dimethylmethylene blue. Values are expressed as the mean ± stand-
ard deviation of nine donors (n = 4 culture dishes per treatment group at each incubation period; *P < 0.05, **P < 0.01, versus control group at 
each incubation time). The H2O2 treated group exhibited a significant decrease in GAG production by chondrocytes as compared with the control 
group at all incubation times. In the antioxidative agent group the level of proteoglycan production tended to increase as compared with the control 
group, although no significant differences were observed between the control groups and antioxidative agent groups at any incubation time.
Figure 3
Chondrocyte replicative capacity under the various oxidative conditions Chondrocyte replicative capacity under the various oxidative conditions. At each subculture (initial subculture at the start of the experiment: 5 × 104 
cells/dish, primary culture), the total number of cells in the dish was determined, and the cells (1 × 105 cells/dish) were placed in a new dish. The 
number of cells that had attached 6 hours after seeding was determined. The increase in cumulative population doublings (number of cell divisions) 
at each subculture (n = 4 per treatment group) was calculated based on the number of cells attached and the cell yield at the time of the next sub-
cultivation. Cell cultures were considered to have achieved their proliferative limit (senescence) when they did not exceed a twofold increase in 4 
weeks. Values are expressed as mean ± standard deviation of four donors. *P < 0.05 and **P < 0.01, versus control group at each incubation time.Available online http://arthritis-research.com/content/7/2/R380
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mean lifespan to cellular senescence was 23 population
doublings in the antioxidative agent treated group, 18 pop-
ulation doublings in the control group, and 14 population
doublings in the ROS-treated group (Fig. 3).
Chondrocyte telomere length under the different 
oxidative conditions
To clarify the effect of oxidative stress on the telomeric
instability in chondrocytes, we analyzed the telomere length
of chondrocytes in the presence of an antioxidative agent
or ROS in vitro (Fig. 4a). After five to six population dou-
blings, telomere lengths of chondrocytes were shorter in
H2O2 treated groups than in control groups at any level of
population doubling. Treatment with an antioxidative agent
resulted in a tendency of chondrocyte telomere length to
elongate (n = 9; Fig. 4b).
Immunohistochemical staining for nitrotyrosine of 
human articular cartilage cultured under different 
oxidative conditions
To examine the influence of an antioxidative agent or ROS
in human articular cartilage, immunohistochemical staining
for nitrotyrosine was evaluated in cartilage samples that
were treated with an antioxidative agent or ROS (H2O2) in
organ culture. Cartilage from an OA patient was cut and
divided into three groups as follows: control group, antioxi-
dative agent (Asc2P) treated group, and H2O2 treated
group. After a 48-hour incubation in explant culture, OA
articular cartilage in both the control group and the H2O2
treated group exhibited positive immunostaining for nitroty-
rosine (Fig. 5a). The degree of nitrotyrosine staining was
higher in the H2O2 treated group than in the control group
(Fig. 5b). In contrast to these two groups, articular cartilage
treated with the antioxidative agent showed less staining
for nitrotyrosine (Fig. 5b).
Catabolic changes to articular cartilage matrix under 
different oxidative conditions in organ culture
To investigate whether oxidative stress resulted in catabolic
changes to the articular cartilage matrix, we examined the
amount of GAG remaining in cartilage tissue and that was
released into the culture medium in organ culture in the
presence of an antioxidative agent or ROS. Catabolic
changes to proteoglycan in the tissue were quantified as
the percentage of proteoglycan remaining in the cartilage
relative to total amount in the culture medium plus cartilage.
During culture, the amount of proteoglycan remaining in the
cartilage tissue in the control group and H2O2-treated
group decreased gradually in a timedependent manner.
Figure 4
Southern blot analysis of chondrocyte telomere lengths in cultured chondrocytes at each passage under the different oxidative conditions Southern blot analysis of chondrocyte telomere lengths in cultured chondrocytes at each passage under the different oxidative conditions. (a) Rep-
resentative image of Southern blot analysis. Telomere lengths in chondrocytes (1 × 106 cells/dish, initial subculture at the start of the experiment: 
chondrocytes at passage 3 or 4) were determined using the terminal restriction fragment (TRF) assay. (b) The mean lengths of the chondrocytes 
were calculated by densitometric molecular weight analysis and were plotted against the number of cell population doublings. *P < 0.05, versus 
control group at each incubation time. ROS, reactive oxygen species.Arthritis Research & Therapy    Vol 7 No 2    Yudoh et al.
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After 72 hours of incubation, the percentage of proteogly-
can remaining in the cartilage tissue was significantly lower
in the H2O2 treated group than in the control group. In con-
trast, the antioxidative agent (Asc2P) treated group exhib-
ited a tendency to maintain tissue proteoglycan even in the
presence of H2O2 during the incubation period we studied
in organ culture (Fig. 6).
Figure 5
Tissue culture of articular cartilage tissue Tissue culture of articular cartilage tissue. (a) Representative immunohistochemical staining for nitrotyrosine in cartilage explants treated with reac-
tive oxygen species (ROS) or an antioxidative agent in tissue culture. Osteoarthritis (OA) cartilage explant from a 67-year-old donor was cut and 
divided into three groups: control group, H2O2 treated group, and antioxidative agent (ascorbic acid-2-O-phosphate [Asc2P]) treated group. After 
the end of the incubation period (48 hours of incubation), the cartilage sections were immunostained with anti-nitrotyrosine antibody. Original magni-
fications are given in parentheses. (b) The number of nitrotyrosine positive cells were counted in the 20 areas of tissue-cultured cartilage at 200× 
magnification (0.785 mm2/field). A statistical analysis of immunostaining was performed. *P < 0.05, **P < 0.01, versus control group.Available online http://arthritis-research.com/content/7/2/R380
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Telomere length of chondrocytes from human articular 
cartilage explants cultured under different oxidative 
conditions
To clarify the effect of oxidative stress on chondrocyte telo-
meric instability in the cartilage, we analyzed the telomere
length of chondrocytes that were isolated from cartilage
explants cultured in the presence of an antioxidative agent
(Asc2P) or ROS (H2O2) in vitro. After 144 hours of incuba-
tion, the telomere length of chondrocytes was significantly
shorter in H2O2 treated groups (lane 4 in Fig. 7a,b) than in
control group (lane 2 in Fig. 7b). Treatment with an antioxi-
dative agent showed a tendency to maintain chondrocyte
telomere length (lane 3 in Fig. 7).
Discussion
The present study clearly demonstrates for the first time
that oxidative stress affects chondrocyte telomeric DNA,
cellular replicative lifespan, chondrocyte function, and car-
tilage matrix proteoglycan structure and composition in
vitro and in vivo. These findings are consistent with a large
body of data showing that reactive oxidative species, such
as NO and ROS, are important in the pathogenesis of OA
[11-16]. More recently, a suggestion that chondrocyte
senescence may contribute to the risk for cartilage degen-
eration by decreasing the ability of the cells to maintain and
to repair cartilage tissue has attracted attention [3-6]. Age-
dependent changes in articular cartilage increase the risk
for joint deterioration that causes the clinical syndrome of
OA. However, the exact mechanism of chondrocyte senes-
cence remains unclear. Our findings, demonstrating the
oxidative stress (ROS) induced telomere erosion and repli-
cative senescence in chondrocytes, suggest the involve-
ment of oxidative stress in both the progression of cartilage
ageing (chondrocyte senescence) and the development of
OA.
Our results also show the presence of oxidative damage in
degenerated cartilage from OA patients. Chondrocytes
have been shown to be capable of producing ROS and NO
[15,20,40]. In the present study, stronger staining for nitro-
tyrosine, a marker of oxidative stress, was observed in
degenerating regions as compared with intact regions from
the same articular cartilage samples. In addition, the degree
of immunostaining was correlated with the level of histolog-
ical change in articular cartilage. These findings suggest
that local accumulation of proteins altered by the reaction
between ROS and NO may be important in the
pathogenesis of OA. Oxidative damage in cartilage may
affect chondrocyte function, resulting in changes in carti-
lage homeostasis that are relevant to cartilage ageing and
the development of OA.
We also measured the antioxidative potential of articular
cartilage tissue using an assay based on reduction in Cu2+
to Cu+ by the combined action of all antioxidants present in
the cartilage sample. Numerous reports have demon-
strated that hypoxia is suitable for chondrocyte proliferation
in vitro [41-43]. During chondrocyte differentiation, hypoxia
may promote the process, although the exact mechanisms
of chondrocyte differentiation have not been investigated to
date. In addition, there is a general consensus that tissue
oxygen partial pressures within articular cartilage decrease
with increasing depth from the cartilage surface to deep
layers [38,44,45]. Oxygen gradients do indeed exist in joint
articular cartilage. These findings suggest that hypoxia may
be required for homeostasis and maintenance of articular
Figure 6
Glycosaminoglycan (GAG) remaining in the cartilage extract treated with reactive oxygen species (ROS) or antioxidative agent in tissue culture Glycosaminoglycan (GAG) remaining in the cartilage extract treated with reactive oxygen species (ROS) or antioxidative agent in tissue culture. Cat-
abolic change in articular cartilage matrix was analyzed by determining the GAG content remaining in the cartilage extract relative to the total amount 
of GAG in the supernatant and the cartilage digest. Values are expressed as mean ± standard deviation of nine donors (three cartilage extracts per 
donor). *P < 0.05, **P < 0.01, versus control group at each incubation time.Arthritis Research & Therapy    Vol 7 No 2    Yudoh et al.
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cartilage as well as chondrocyte cell growth and differenti-
ation. During the development of OA, mechanical and
chemical stresses may affect cellular adaptation to hypoxia,
consequently leading to oxidative damage and changes in
the microenvironment due to oxidative damage, resulting in
the downregulation of chondrocyte synthesis. Indeed, our
results revealed that antioxidative potential was significantly
lower in degenerating regions than in intact regions from
the same articular cartilage sample in OA.
To clarify the involvement of oxidative damage in the devel-
opment of OA, we focused on chondrocyte telomere insta-
bility. Cumulative cell damage from oxidative stress
provides an alternative explanation for cellular senescence.
Oxygen free radicals directly damage guanine repeats in
telomeric DNA, resulting in telomere erosion regardless of
cell division [16-19]. DNA single strand damage by oxygen
free radicals results in telomere shortening during DNA rep-
lication. Oxidative stress increases the telomere shortening
rate by up to one order of magnitude [46]. From these find-
ings, we postulated that oxidative stress directly induces
chondrocyte telomere instability in OA cartilage tissue,
resulting in chondrocyte senescence with no requirement
for cell division. Our results, demonstrating chondrocyte
telomere shortening in the presence of H2O2, at a noncyto-
toxic concentration, supports this hypothesis.
In addition to oxidative stress-induced telomere shortening,
chondrocytes under chemical oxidative stress showed
lower replicative lifespan and proteoglycan production as
compared with normal chondrocytes in vitro. These find-
ings also indicate that oxidative stress affects chondrocyte
viability, and replicative potential and function, as well as
telomere erosion.
We investigated catabolic changes to articular cartilage
matrix under different oxidative conditions in tissue culture.
The degree of immunostaining for nitrotyrosine was signifi-
cantly higher in ROS (H2O2) treated cartilage tissues than
in control cartilage tissues that were derived from the same
articular cartilage. In addition, the GAG released to the
medium was increased in the presence of ROS, suggest-
ing that oxidative damage induces catabolic changes to
cartilage matrix proteoglycan in articular cartilage. These
observations led us to the hypothesis that oxidative stress
may induce catabolic changes in cartilage matrix, conse-
quently leading to the development of OA. This hypothesis
is supported by the results of the present study, demon-
Figure 7
Telomere length of cultured chondrocytes from tissue cultured cartilage explants under the different oxidative conditions Telomere length of cultured chondrocytes from tissue cultured cartilage explants under the different oxidative conditions. After 144 hours' incubation 
of tissue culture, chondrocytes were isolated from cartilage explants, which were incubated in the presence or absence of H2O2 (0.1 µmol/l) or 
ascorbic acid-2-O-phosphate (Asc2P; 100.0 µmol/l). Telomere lengths in chondrocytes (1 × 106chondrocytes of passage 3–4 after isolation) were 
determined using the terminal restriction fragment (TRF) assay. (a) Representative image of telomere length assay of chondrocytes after 144 hours 
of incubation. Lane 1, pretreated group (telomere length of isolated chondrocytes from cartilage explants before tissue culture); lane 2, Asc2P + 
H2O2 treated group; lane 3, control group; lane 4, H2O2 treated group. (b) Treatment with Asc2P (lane 2) showed a tendency to elongate the mean 
telomere length of chondrocytes in comparison with control. Mean telomere length in H2O2 treated group was significantly shorter than in the control 
group (n = 9; P < 0.05).Available online http://arthritis-research.com/content/7/2/R380
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strating that treatment of articular cartilage with the antiox-
idative agent ascorbic acid resulted in less
immunopositivity for nitrotyrosine and maintenance of GAG
content in articular cartilage in tissue culture.
Interestingly, treatment of cultured cartilage with an antiox-
idative agent not only inhibited GAG loss but also main-
tained telomere length of chondrocytes from cultured
cartilage in contrast to data obtained from cultured carti-
lage under normal or ROS-treated conditions. These
findings may very well indicate the role played by endog-
enous oxidative agents in catabolic changes to cartilage
matrix proteoglycan and telomere length. This is an impor-
tant observation and will validate the hypothesis that oxida-
tive agents play a role in situ in chondrocytes and in
cartilage changes in OA. These results also support the
concept that antioxidative agents may prevent oxidative
stress-induced chondrocyte dysfunction and degeneration
in cartilage.
The findings of the present study suggest that cumulative
oxidative stress leads to a decrease in antioxidative capac-
ity in articular cartilage, resulting in chondrocyte telomere
shortening, regardless of cell proliferation. Oxidative stress
may be closely involved in telomere erosion, cellular senes-
cence in chondrocytes and resultant cartilage ageing.
Conclusion
This study provides insight into the involvement of oxidative
stress in the pathogenesis of OA from the viewpoint of oxi-
dative stress induced genomic instability, especially tel-
omere erosion, and chondrocyte senescence. Our findings
clearly show the presence of oxidative stress in degenerat-
ing cartilage, and the resultant telomere erosion and dys-
function of chondrocytes in vitro and in vivo, suggesting a
role for oxidative stress in the development of OA. Also, our
results suggest that antioxidative agents are effective in
preventing and overcoming oxidative stress induced carti-
lage degeneration. New efforts to prevent the development
and progression of OA may include strategies and interven-
tions aimed at reducing oxidative damage in articular
cartilage.
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